News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
680,831 Results
Type
Article (50818)
Company Profile (221)
Press Release (629792)
Section
Business (190914)
Career Advice (2971)
Deals (34818)
Drug Delivery (108)
Drug Development (78680)
Employer Resources (170)
FDA (16609)
Job Trends (15319)
News (329250)
Policy (32095)
Tag
Academia (2878)
Alliances (51345)
Alzheimer's disease (1393)
Approvals (16576)
Artificial intelligence (229)
Bankruptcy (318)
Best Places to Work (12356)
Biotechnology (158)
Breast cancer (237)
Cancer (1780)
Cardiovascular disease (138)
Career advice (2482)
CAR-T (135)
Cell therapy (387)
Clinical research (63125)
Collaboration (713)
Compensation (371)
COVID-19 (2709)
C-suite (169)
Data (1668)
Diabetes (218)
Diagnostics (6720)
Earnings (71502)
Employer resources (150)
Events (106515)
Executive appointments (595)
FDA (17544)
Funding (633)
Gene therapy (271)
GLP-1 (672)
Government (4514)
Healthcare (20332)
Infectious disease (2826)
Inflammatory bowel disease (130)
Interviews (566)
IPO (16620)
Job creations (3433)
Job search strategy (2070)
Layoffs (444)
Legal (7414)
Lung cancer (263)
Manufacturing (248)
Medical device (14294)
Medtech (14299)
Mergers & acquisitions (18636)
Metabolic disorders (561)
Neuroscience (1825)
NextGen: Class of 2025 (7156)
Non-profit (4966)
Northern California (2141)
Obesity (305)
Opinion (240)
Patents (168)
People (55158)
Phase I (19787)
Phase II (27898)
Phase III (20783)
Pipeline (719)
Postmarket research (2365)
Preclinical (8299)
Radiopharmaceuticals (260)
Rare diseases (352)
Real estate (5745)
Regulatory (21988)
Research institute (2583)
Resumes & cover letters (477)
Southern California (1842)
Startups (3631)
United States (19161)
Vaccines (671)
Weight loss (209)
Date
Today (11)
Last 7 days (624)
Last 30 days (2623)
Last 365 days (36009)
2025 (4697)
2024 (36900)
2023 (42134)
2022 (53454)
2021 (58154)
2020 (56905)
2019 (50195)
2018 (38025)
2017 (33963)
2016 (32790)
2015 (38280)
2014 (28888)
2013 (23849)
2012 (25699)
2011 (26390)
2010 (24049)
Location
Africa (896)
Arizona (169)
Asia (40263)
Australia (7188)
California (4878)
Canada (1738)
China (399)
Colorado (225)
Connecticut (247)
Europe (93033)
Florida (710)
Georgia (176)
Illinois (489)
Indiana (269)
Maryland (786)
Massachusetts (3797)
Michigan (218)
Minnesota (353)
New Jersey (1392)
New York (1387)
North Carolina (907)
Northern California (2141)
Ohio (180)
Pennsylvania (1120)
South America (1239)
Southern California (1842)
Texas (716)
Utah (152)
Washington State (488)
680,831 Results for "gyros protein technologies gyros ab merged with protein technologies".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Gyros Protein Technologies Introduces Gyrolab Generic Anti-AAV Kit to Support Gene Therapy Development
Gyros Protein Technologies AB, a pioneer in automated nanoliter-scale immunoassays and leading provider of peptide synthesizers today announced the introduction of its Gyrolab® Generic Anti-Adeno Associated Virus (AAV) Kit.
June 17, 2024
·
2 min read
Press Releases
Gyros Protein Technologies Introduces Gyrolab HEK293 HCP Type SN and Type CL Kit Reagents to Support Biotherapeutic Development
February 5, 2025
·
2 min read
Drug Development
Gyros Protein Technologies Introduces Gyrolab Generic Rodent ADA Kit Reagents to Support Preclinical Immunogenicity Assessment
Gyros Protein Technologies AB announced the introduction of Gyrolab® Generic Rodent Anti-Drug Antibody Kit Reagents for the detection of circulating immune complexes of human IgG with rodent anti-human IgG.
May 2, 2024
·
2 min read
Gyros Protein Technologies and Biotage partner to advance peptide purification efficiency with new automated solution
Gyros Protein Technologies AB and Biotage announced a partnership to offer Biotage® PeptiPEC, based on Gyros’ PurePep® EasyClean catch and release technology, on Biotage® Extrahera™ automated sample preparation system.
December 7, 2023
·
2 min read
Gyros Protein Technologies Introduces PurePep EasyClean Auto Kit for Automated Parallel Peptide Purification
Gyros Protein Technologies AB announced the launch of its PurePep® EasyClean Auto Kit for the automated parallel purification of peptides, accelerating downstream processes for research, development, and production of simple to complex peptide drugs and therapies.
July 27, 2023
·
2 min read
Gyros Protein Technologies Introduces Gyrolab Generic Cyno ADA Kit Reagents to Support Pre-Clinical Immunogenicity Assessment
Gyros Protein Technologies AB, a leading provider of peptide synthesizers and reagents and a pioneer in automated nanoliter-scale immunoassays, today announced the introduction of Gyrolab® Generic Cyno Anti-Drug Antibodies (ADA) Kit Reagents, for the detection of circulating immune complexes of human IgG with cyno anti-human IgG.
May 2, 2023
·
2 min read
Gyros Protein Technologies Adds Gyrolab® Biomarker Kits to Expand Range of Ready-to-Use Kits and Reagents
Gyros Protein Technologies AB, a leading provider of peptide synthesizers and reagents and a pioneer in automated nanoliter-scale immunoassays, introduced Gyrolab® Human Cytokine Kit Reagents, the first in a range of new biomarker kits.
November 29, 2022
·
2 min read
Sponsored
SignalChem’s Tau Proteins: Accelerating Neurodegenerative Disease Research
SignalChem Biotech provides diverse recombinant Tau proteins for research, helping advance tau-targeted therapies that may modify disease progression in Alzheimer’s and related tauopathies.
November 18, 2024
·
3 min read
Press Releases
Matwings Technology Raised Series A Funding of Tens of Millions USD to Redefine Protein Design
December 26, 2024
·
3 min read
Press Releases
Avantor to Distribute Quantum-Si’s Next-Generation Protein Sequencing™ Technology
November 20, 2024
·
6 min read
1 of 68,084
Next
